-
公开(公告)号:US20210122785A1
公开(公告)日:2021-04-29
申请号:US17254503
申请日:2019-06-18
Applicant: BicycleTx Limited
Inventor: Daniel Teufel , Gemma MUDD , Silvia PAVAN
Abstract: A peptide ligand specific for IL-17 comprising a polypeptide comprising three residues selected from cysteine, L-2,3-diaminopropionic acid (Dap), N-beta-alkyl-L-2,3-diaminopropionic acid (N-AlkDap) and N-beta-haloalkyl-L-2,3-diaminopropionic acid (N-HAlkDap), with the proviso that at least one of said three residues is selected from Dap, N-AlkDap or N-HAlkDap, the said three residues being separated by at least two loop sequences, and a molecular scaffold, the peptide being linked to the scaffold by covalent alkylamino linkages with the Dap or N-AlkDap or N-HAlkDap residues of the polypeptide and by thioether linkages with the cysteine residues of the polypeptide when the said three residues include cysteine, such that two polypeptide loops are formed on the molecular scaffold. Also provided are drug conjugates comprising the peptide ligands conjugated to one or more effector groups and pharmaceutical compositions comprising the conjugates.
-
公开(公告)号:US20210101933A1
公开(公告)日:2021-04-08
申请号:US17080021
申请日:2020-10-26
Applicant: BicycleTx Limited
Inventor: Liuhong CHEN , Rachid LANI , Kevin MCDONNELL , Gemma MUDD , Peter U. PARK , Punit UPADHYAYA
IPC: C07K7/08 , A61K47/59 , A61K47/60 , A61K47/64 , A61K47/66 , A61P35/00 , C07K7/64 , C07K14/705 , C07K17/02 , C07K17/14 , C07K2/00
Abstract: The present invention relates to multimers of polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. The invention also describes the multimerization of polypeptides through various chemical linkers and hinges of various lengths and rigidity using different sites of attachments within polypeptides. In particular, the invention describes multimers of peptides which are high affinity binders and activators of CD137. The invention also includes drug conjugates comprising said peptides, conjugated to one or more effector and/or functional groups, to pharmaceutical compositions comprising said peptide ligands and drug conjugates and to the use of said peptide ligands and drug conjugates in preventing, suppressing or treating a disease or disorder mediated by CD137.
-
公开(公告)号:US20210069287A1
公开(公告)日:2021-03-11
申请号:US16941588
申请日:2020-07-29
Applicant: BicycleTx Limited
Inventor: Gemma Mudd , Punit Upadhyaya , Kevin McDonnell , Johanna Lahdenranta
Abstract: The present invention relates to a heterotandem bicyclic peptide complex which comprises a first peptide ligand, which binds to EphA2, conjugated via a linker to two second peptide ligands, which bind to CD137. The invention also relates to the use of said heterotandem bicyclic peptide complex in preventing, suppressing or treating cancer.
-
公开(公告)号:US20210046145A1
公开(公告)日:2021-02-18
申请号:US17010438
申请日:2020-09-02
Applicant: BicycleTx Limited
Inventor: Paul John Beswick , Gabriela Ivanova-Berndt , Gemma Elizabeth Mudd , Silvia Pavan , Michael Skynner , Daniel Paul Teufel , Katerine Van Rietschoten
IPC: A61K38/00 , A61P35/00 , A61K47/10 , A61K38/12 , C12N9/64 , C07K7/08 , C12N9/88 , C07K7/64 , A61K47/62
Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
-
公开(公告)号:US20190307836A1
公开(公告)日:2019-10-10
申请号:US16372692
申请日:2019-04-02
Applicant: BicycleTx Limited
Inventor: Nicholas Keen , Kevin McDonnell , Peter Park , Punit Upadhyaya
Abstract: The present invention relates to heterotandem bicyclic peptide complexes which comprise a first peptide ligand, which binds to a component present on an immune cell, conjugated via a linker to a second peptide ligand, which binds to a component present on a cancer cell. The invention also relates to the use of said heterotandem bicyclic peptide complexes in preventing, suppressing or treating cancer.
-
公开(公告)号:US20180311300A1
公开(公告)日:2018-11-01
申请号:US15964599
申请日:2018-04-27
Applicant: BicycleTx Limited
Inventor: Paul John Beswick , Gabriela Ivanova-Berndt , Gemma Elizabeth Mudd , Silvia Pavan , Michael Skynner , Daniel Paul Teufel , Katerine Van Rietschoten
Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
-
公开(公告)号:US20250002536A1
公开(公告)日:2025-01-02
申请号:US18802865
申请日:2024-08-13
Applicant: BicycleTx Limited
Inventor: Stephen J. Blakemore , Tara Gelb , Nicholas Keen , Michael Rigby
IPC: C07K7/08 , A61K31/40 , A61K31/5375 , A61K38/00 , A61K38/10 , A61K47/55 , A61K47/64 , A61K47/65 , A61P35/00
Abstract: The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which are high affinity binders of Nectin-4. The invention also includes drug conjugates comprising said peptides, conjugated to one or more effector and/or functional groups, to pharmaceutical compositions comprising said peptide ligands and drug conjugates and to the use of said peptide ligands and drug conjugates in preventing, suppressing or treating a disease or disorder mediated by Nectin-4.
-
公开(公告)号:US20240240255A1
公开(公告)日:2024-07-18
申请号:US18021748
申请日:2021-08-17
Applicant: BicycleTx Limited
Inventor: Stephen J. BLAKEMORE , Tara GELB , Sean M. SANTOS , Heather B. COHEN
IPC: C12Q1/6886 , A61K39/00 , A61K47/64 , G01N33/574
CPC classification number: C12Q1/6886 , A61K47/6415 , G01N33/57407 , A61K2039/505 , C12Q2600/106 , C12Q2600/158 , G01N2800/52
Abstract: The present invention relates to a Bicycle toxin conjugate or a Bicycle tumor targeted immune agonist specific for Nectin-4, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof, and uses thereof.
-
公开(公告)号:US20240083945A1
公开(公告)日:2024-03-14
申请号:US18271348
申请日:2022-01-10
Applicant: BicycleTx Limited
Inventor: Nicholas KEEN , Liuhong CHEN , Maximilian HARMAN , Michael SKYNNER , Paul BESWICK , Yuliya DEMYDCHUK
Abstract: The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which are high affinity binders of the COVID-19 nucleocapsid protein (N-protein). The invention also includes pharmaceutical compositions comprising said polypeptides and to the use of said polypeptides in suppressing or treating a disease or disorder mediated by the COVID-19 nucleocapsid protein (N-protein), such as infection of COVID-19 or for providing prophylaxis to a subject at risk of infection of COVID-19.
-
公开(公告)号:US11912792B2
公开(公告)日:2024-02-27
申请号:US17820286
申请日:2022-08-17
Applicant: BicycleTx Limited
Inventor: Paul Beswick , Liuhong Chen , Gemma Mudd , Peter Park , Katerine Van Rietschoten , Michael Rigby
IPC: A61K38/00 , A61K38/10 , A61K47/55 , A61K47/64 , A61K47/65 , A61P35/00 , C07K7/08 , A61K31/40 , A61K31/5375
CPC classification number: C07K7/08 , A61K38/10 , A61K47/55 , A61K47/64 , A61K47/65 , A61P35/00 , A61K31/40 , A61K31/5375 , A61K38/00
Abstract: The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which are high affinity binders of Nectin-4. The invention also includes drug conjugates comprising said peptides, conjugated to one or more effector and/or functional groups, to pharmaceutical compositions comprising said peptide ligands and drug conjugates and to the use of said peptide ligands and drug conjugates in preventing, suppressing or treating a disease or disorder mediated by Nectin-4.
-
-
-
-
-
-
-
-
-